ES2003774A6 - Procedimiento para preparar nuevas 8 alfa-acilamino-ergolinas - Google Patents

Procedimiento para preparar nuevas 8 alfa-acilamino-ergolinas

Info

Publication number
ES2003774A6
ES2003774A6 ES8700163A ES8700163A ES2003774A6 ES 2003774 A6 ES2003774 A6 ES 2003774A6 ES 8700163 A ES8700163 A ES 8700163A ES 8700163 A ES8700163 A ES 8700163A ES 2003774 A6 ES2003774 A6 ES 2003774A6
Authority
ES
Spain
Prior art keywords
compound
alkyl
formula
alpha
react
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES8700163A
Other languages
English (en)
Spanish (es)
Inventor
Rene Ziegler
Peter Nuemann
Walter Haefliger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of ES2003774A6 publication Critical patent/ES2003774A6/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/10—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hetero atoms directly attached in position 8
    • C07D457/12—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Otolaryngology (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ES8700163A 1986-01-24 1987-01-22 Procedimiento para preparar nuevas 8 alfa-acilamino-ergolinas Expired ES2003774A6 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3602058 1986-01-24

Publications (1)

Publication Number Publication Date
ES2003774A6 true ES2003774A6 (es) 1988-11-16

Family

ID=6292510

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8700163A Expired ES2003774A6 (es) 1986-01-24 1987-01-22 Procedimiento para preparar nuevas 8 alfa-acilamino-ergolinas

Country Status (18)

Country Link
JP (1) JPS62190184A (da)
KR (1) KR870007175A (da)
AU (1) AU6791487A (da)
BE (1) BE1000039A4 (da)
DK (1) DK35787A (da)
ES (1) ES2003774A6 (da)
FI (1) FI870293A7 (da)
FR (1) FR2595699A1 (da)
GB (1) GB2185743A (da)
GR (1) GR870093B (da)
HU (1) HUT45248A (da)
IL (1) IL81355A0 (da)
IT (1) IT1216783B (da)
LU (1) LU86743A1 (da)
NL (1) NL8700046A (da)
PT (1) PT84184A (da)
SE (1) SE8700250L (da)
ZA (1) ZA87520B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8714767D0 (en) * 1987-06-24 1987-07-29 Erba Farmitalia Egoline derivatives
ATE107647T1 (de) * 1984-04-09 1994-07-15 Schering Ag 2-substituierte ergolin-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
DK338789A (da) * 1988-07-15 1990-01-16 Schering Ag 2-substituerede ergolinylurinstofderivater og fremgangsmaade til fremstilling deraf, deres anvendelse som laegemidler samt mellemprodukter til fremstilling deraf
DE3915950A1 (de) * 1989-05-12 1990-11-15 Schering Ag 8(alpha)-acylamino-ergoline, ihre herstellung und verwendung als arzneimittel
EP2723735A4 (en) * 2011-06-23 2015-02-18 Map Pharmaceuticals Inc NOVEL ANALOGUES OF FLUORO-ERGOLINE
AU2012355982A1 (en) * 2011-12-19 2014-07-10 Map Pharmaceuticals, Inc. Novel iso-ergoline derivatives
BR112017015510A2 (pt) * 2015-01-20 2018-01-30 Xoc Pharmaceuticals Inc composto de fórmula estrutural (i), método de tratamento e/ou prevenção, método de agonização do receptor d2 em um indivíduo, método de antagonização do receptor d3 em um indivíduo, método de agonização do receptor 5-ht1d em um indivíduo, método de agonização do receptor 5-ht1a em um indivíduo, método de agonização seletiva do receptor 5-ht1d em vez do receptor 5-ht1b em um indivíduo, método de agonização seletiva do re-ceptor 5-ht2c em vez do receptor 5-ht2a ou 5-ht2b em um indivíduo, método de agonização do receptor 5-ht2c em um indivíduo, método de fornecimento de atividade antagonista funcional no receptor 5-ht2b ou receptor 5-ht7, e, método de fornecimento de atividade antagonista funcional nos receptores adrenérgicos em um indivíduo
CN113149982A (zh) 2015-01-20 2021-07-23 Xoc制药股份有限公司 麦角灵化合物及其用途
JP2020522504A (ja) 2017-06-01 2020-07-30 エックスオーシー ファーマシューティカルズ インコーポレイテッドXoc Pharmaceuticals, Inc 多環式化合物およびそれらの用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1517971A (en) * 1974-07-19 1978-07-19 Sandoz Ltd 8alpha-substituted ergoline i derivatives
CH615929A5 (en) * 1975-06-02 1980-02-29 Sandoz Ag Process for the preparation of novel ergoline compounds
CH664568A5 (de) * 1984-01-12 1988-03-15 Sandoz Ag 8-alpha-acylaminoergoline.

Also Published As

Publication number Publication date
ZA87520B (en) 1988-09-28
LU86743A1 (fr) 1987-09-03
BE1000039A4 (fr) 1987-12-15
NL8700046A (nl) 1987-08-17
DK35787A (da) 1987-07-25
KR870007175A (ko) 1987-08-17
FI870293A7 (fi) 1987-07-25
PT84184A (pt) 1987-02-01
SE8700250D0 (sv) 1987-01-22
GR870093B (en) 1987-05-25
DK35787D0 (da) 1987-01-22
FI870293A0 (fi) 1987-01-23
HUT45248A (en) 1988-06-28
IL81355A0 (en) 1987-08-31
FR2595699A1 (fr) 1987-09-18
GB8701274D0 (en) 1987-02-25
GB2185743A (en) 1987-07-29
SE8700250L (sv) 1987-07-25
AU6791487A (en) 1987-07-30
IT8747551A0 (it) 1987-01-22
IT1216783B (it) 1990-03-14
JPS62190184A (ja) 1987-08-20

Similar Documents

Publication Publication Date Title
ES8706130A1 (es) Procedimiento para la preparacion de 3-ariluracilos
ES8705353A1 (es) Procedimiento de producir derivados dihidro- y tetradhidroquinolinicos
ES2033675T3 (es) Un procedimiento para preparar un compuesto de n-benzoil urea.
ATE106382T1 (de) Herstellung von 4,6-dinitro-2-halo-1,3- benzendiol.
ES8707250A1 (es) Procedimiento para preparar acidos fosfonicos y derivados de los mismos
FI872636A0 (fi) Substituerade 4-bensyl -piperazinylfoereningar.
CO4410185A1 (es) Nueva benzamidina, su preparacion y su empleo como medica- mento
ATE40947T1 (de) Verwendung von cystein-derivaten oder deren salzen, zur steigerung der insulinsekretion der langerhans'schen inseln der bauchspeicheldruese.
MY101618A (en) Intermediates for the production of epipodophyloxin and related compounds and processes for the preparation and use thereof
ES8704153A1 (es) Un procedimiento para preparar derivados de pirimidina
ES8506655A1 (es) Procedimiento para la obtencion de un derivado de fenilsulfonilguanidina
ES2040222T3 (es) Procedimiento para preparar ciertas 2-benzoil-2,3,5-ciclohexanotrionas.
DE3685263D1 (de) Biologisch aktive fluoreszierende zyklische nukleotide.
ES2043738T3 (es) Procedimiento para la reduccion de cetonas.
HU9400587D0 (en) Herbicidal sulphonyl ureas, process and intermediates for producing the same
ES8706152A1 (es) Procedimiento para preparar un nuevo derivado de octahidroindol (2,3-a) quinolizina
ATE38829T1 (de) Phenylbenzoylharnstoffe.
ES8504794A1 (es) Un procedimiento para la preparacion de una quinazolina
IT1215251B (it) Farmaceutiche che li contengono. composti ad attivita'antiaggregante piastrinica, procedimento per la loro preparazione e composizioni
SE7907540L (sv) Diuretiska medel
PH18629A (en) Substituted 2,3-alkylene bis (oxy) benzoic acid derivatives
ES548497A0 (es) Procedimiento para preparar compuestos de 3-amino-2,3-dihi- dro-1-benzoxepina
SE8801166D0 (sv) Substituted 1,3-dioxolane and 1,3-dioxane derivatives, processes for the production and their use
JPS5737594B2 (da)
JO1412B1 (en) Replaced 4 benzyl piperazineil compounds